Diet, H pylori infection and gastric cancer:: Evidence and controversies

被引:50
作者
Rocco, Alba [1 ]
Nardone, Gerardo [1 ]
机构
[1] Univ Naples Federico II, Dipartimento Med Clin & Sperimentale, Unita Gastroenterol, I-80131 Naples, Italy
关键词
gastric cancer; H pylori; diet; observational studies; interventional dietary trials; GREEN-TEA CONSUMPTION; NESTED CASE-CONTROL; N-NITROSO COMPOUNDS; SERUM PEPSINOGEN-I; STOMACH-CANCER; RISK-FACTORS; NUTRIENT INTAKE; FOLLOW-UP; JIANGSU PROVINCE; CAGA SEROPOSITIVITY;
D O I
10.3748/wjg.v13.i21.2901
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Despite decreasing incidence and mortality rates, gastric cancer (GC) still remains the fourth most common cancer and the second most common cause of cancer-related deaths worldwide. Due to the limited treatment options, at present, prevention is likely to be the only effective means of controlling this disease. The success of a prevention strategy depends upon the understanding of etiological and pathogenic mechanisms underlying gastric carcinogenesis. The etiology of GC is multi-factorial, however, in the recent years, mounting evidence suggests that environmental factors play a key role. The most important environmental factors implicated in the pathogenesis of GC are diet and H pylori infection. Thus, modifications in lifestyle and dietary habit associated with eradication of H pylori infection could hypothetically represent the most promising potential targets for GC prevention. In this review we will address the evidence and the controversies on the role of these agents in non-cardia GC by focusing on retrospective and prospective observational studies and interventional trials. (C) 2007 The WJG Press. All rights reserved.
引用
收藏
页码:2901 / 2912
页数:12
相关论文
共 179 条
[1]
CONSUMPTION OF ALCOHOL, COFFEE, AND TOBACCO, AND GASTRIC-CANCER IN SPAIN [J].
AGUDO, A ;
GONZALEZ, CA ;
MARCOS, G ;
SANZ, M ;
SAIGI, E ;
VERGE, J ;
BOLEDA, M ;
ORTEGO, J .
CANCER CAUSES & CONTROL, 1992, 3 (02) :137-143
[2]
*AM CANC SOC, 2000, EST NEW CANC CAS DEA
[3]
[Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P1
[4]
ARCHIMANDRITIS A, 1993, ITAL J GASTROENTEROL, V25, P368
[5]
Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer [J].
Aromaa, A ;
Kosunen, TU ;
Knekt, P ;
Maatela, J ;
Teppo, L ;
Heinonen, OP ;
Harkonen, M ;
Hakama, MK .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1996, 144 (02) :142-149
[6]
ASAKA M, 1994, CANCER, V73, P2691, DOI 10.1002/1097-0142(19940601)73:11<2691::AID-CNCR2820731107>3.0.CO
[7]
2-2
[8]
ASAKA M, 1995, EUR J GASTROEN HEPAT, V7, pS7
[9]
Azuma T, 1998, CANCER, V82, P1013, DOI 10.1002/(SICI)1097-0142(19980315)82:6<1013::AID-CNCR2>3.0.CO
[10]
2-F